- European shares hover near record highs as AI concerns weigh on tech stocks
European shares hovered near record highs, with the STOXX 600 gaining 0.09% despite global market weakness driven by AI concerns. Technolog...
16 Nov, 2026, 02.53 PM IST
Healthy eating, GLP-1 trend make air fryers a kitchen staple as sales doubleAir fryer sales in India have experienced significant growth, reaching nearly ₹1,000 crore in annual sales. The surge in demand is attribut...
12 Nov, 2026, 12.26 AM IST
Arnold Schwarzenegger’s son Joseph Baena makes pro bodybuilding debut: Check his diet, workout routine and views on steroidsJoseph Baena proudly secured fifth place in the Classic Physique Open division during his professional bodybuilding debut at the INBA PNBA ...
11 Nov, 2026, 04.14 PM IST
GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label abou...
11 Nov, 2026, 12.16 AM IST
US FDA adds rare vision-loss warning to popular GLP-1 drugsThe US FDA will add a warning about a rare eye condition that can cause permanent vision loss to the labels of all GLP-1 drugs, including O...
10 Nov, 2026, 10.41 PM IST
While the world nursed a hangover, India ordered another roundIndia’s alcohol consumption rose 10% in the first half of 2026, even as volumes across 21 major markets fell 1%, according to IWSR data sha...
10 Nov, 2026, 08.25 PM IST
India begins pouring in a bigger glass when global alcohol demand takes a hitAlcohol consumption in India increased by 10% in early 2026, contrasting with declines in other major markets. Beer led the growth, with a ...
10 Nov, 2026, 05.56 PM IST
Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDAEli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (U...
10 Nov, 2026, 01.13 AM IST
These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...
05 Nov, 2026, 11.49 AM IST
Dr Reddy's Laboratories receives ANVISA approval for generic semaglutide injection in BrazilDr Reddy’s Laboratories obtained marketing authorisation from Brazil’s ANVISA for a generic semaglutide injection. The product will be avai...
05 Nov, 2026, 10.19 AM IST
Lindt investors seek board shake-up at chocolate maker after CEO ouster: ReportInfluential investors of Lindt & Spruengli are calling for changes in the board following the CEO's ousting. The company faced significant ...
04 Nov, 2026, 11.45 AM IST
US Markets Today: US stocks end lower as Alphabet revenue miss revives AI capex jittersWall Street ended the day on a sour note, as Alphabet's revenue shortfall cast a shadow over the AI investment landscape and overall market...
30 Oct, 2026, 01.46 AM IST
Mark Cuban says AI hack agents are like cockroaches, but can be controlledCuban, famous for his role on business reality show "Shark Tank" and his involvement in the Dallas Mavericks NBA team, ventured into health...
24 Oct, 2026, 11.40 AM IST
GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan saysThe China-India-Brazil market for GLP-1 weight-loss drugs could expand to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan esti...
23 Oct, 2026, 03.50 PM IST
Heineken document reveals worries over weight-loss drugs and beer salesHeineken has warned UK pubs about the increasing impact of weight-loss drugs on beer sales. These medications may reduce consumers' desire ...
23 Oct, 2026, 11.53 AM IST
Ozempic wave boosts US cobblers and tailors as Americans tighten their beltsConsumers in the US are experiencing significant changes in their wardrobes due to weight-loss medications. Many individuals are opting for...
22 Oct, 2026, 11.52 AM IST
Beauty firms chase 'Ozempic face' market as weight-loss drugs boomGalderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...
21 Oct, 2026, 11.33 AM IST